In a patient who received >50 Gy radiation, had recent dental extractions, has diabetes and a smoking history, how should mandibular osteoradionecrosis be classified using the Notani, Marx, and Radiation Oncology Group systems?

Classification of Mandibular Osteoradionecrosis Using Multiple Staging Systems

This patient with >50 Gy radiation, recent dental extractions, diabetes, and smoking history represents a high-risk profile for severe ORN and should be classified using contemporary staging systems that guide treatment decisions, though the 2024 ISOO-MASCC-ASCO guideline notably moved away from traditional Notani, Marx, and RTOG systems in favor of the ClinRad staging system that better correlates with surgical management.

Understanding the Classification Challenge

The provided evidence reveals an important paradigm shift: the most recent high-quality guideline 1 does not endorse the Notani, Marx, or Radiation Oncology Group classification systems. Instead, the 2024 ISOO-MASCC-ASCO guideline introduces functional descriptors (partial thickness vs. full thickness ORN) and references the ClinRad staging system (stages I-III) as the preferred framework 1.

Why Traditional Systems Are Being Replaced

The guideline panel explicitly states they "did not find consensus in an established staging system that suited this severity threshold" for guiding surgical decision-making 1. This reflects the clinical reality that older classification systems don't adequately predict treatment needs or outcomes.

Contemporary Classification Approach (2024 Guideline)

ClinRad Staging System (Preferred)

Stage I (Partial Thickness):

• Disease extent where removal of necrotic bone leaves sufficient structural integrity
• No risk of oroantral/oronasal defect (maxilla) or pathological fracture (mandible)
• Managed with transoral minor intervention: debridement, sequestrectomy, alveolectomy, soft tissue flap closure 1

Stage II (Variable - Can Be Partial or Full Thickness):

• Selected cases may be partial thickness (managed conservatively)
• More extensive cases approach full thickness requiring segmental resection 1
• Defects <2.5 cm may heal spontaneously; larger defects need vascularized tissue 1

Stage III (Full Thickness):

• Removal of necrotic bone would result in oroantral/oronasal defect or pathological fracture
• Requires segmental maxillectomy or mandibulectomy with free flap reconstruction 1

Your Patient's Risk Profile

This patient has multiple high-risk factors that significantly elevate ORN severity:

• >50 Gy radiation dose: The guideline specifically identifies ≥50 Gy as elevated risk 1
• Recent dental extractions: Post-radiotherapy extractions carry OR = 8.38 for ORN development 2 and OR = 3.228 3
• Diabetes: Associated with OR = 4.467 for ORN 3 and doubles osteoradionecrosis risk 4
• Smoking history: OR = 4.438 for ORN development 3 and OR = 2.56 in meta-analysis 2

Clinical Implications

This combination suggests the patient likely has or will develop more advanced disease requiring aggressive management. The guideline emphasizes that patients with these risk factors who undergo post-RT dental extractions are at substantially elevated risk for severe ORN 1.

Historical Classification Systems (For Reference Only)

While not endorsed by current guidelines, understanding these systems may be necessary for:

• Reviewing older literature
• Communicating with providers using legacy terminology
• Institutional protocols not yet updated

Notani Classification (Historical)

Based on clinical and radiographic extent:

• Grade I: ORN confined to alveolar bone
• Grade II: ORN limited to mandible above inferior dental canal
• Grade III: ORN extending below inferior dental canal, pathologic fracture, or skin fistula

Marx Classification (Historical)

Based on response to hyperbaric oxygen:

• Stage I: Responds to HBO therapy
• Stage II: Does not respond to HBO, requires surgery
• Stage III: Refractory to HBO and surgery

Critical caveat: The 2024 guideline explicitly recommends against routine prophylactic HBO (low-weak evidence) 1, making Marx classification less clinically relevant.

RTOG/EORTC Grading (Historical)

• Grade 1: Asymptomatic, radiographic changes only
• Grade 2: Moderate symptoms, medical management
• Grade 3: Severe symptoms requiring surgical intervention
• Grade 4: Life-threatening complications

Practical Management Algorithm for This Patient

Immediate Assessment

1. Determine disease extent through clinical examination and imaging (CT most commonly used 2)
2. Assess thickness involvement: Can all necrotic bone be removed while maintaining structural integrity?
3. Evaluate systemic factors: Ensure patient is cancer-free before medical therapies 1

Treatment Pathway Based on Extent

If Partial Thickness (ClinRad I-II):

• Start with pentoxifylline 400 mg twice daily + tocopherol 1,000 IU daily + antibiotics + prednisolone 1
• Consider transoral minor surgical intervention if medical management fails 1
• Close monitoring for progression

If Full Thickness (ClinRad III or selected II):

• Segmental mandibulectomy with free flap reconstruction is recommended 1
• Osteomyocutaneous free flaps preferred (92% success rate) 1
• HBO may be considered in conjunction with surgery (most benefit in mild cases) 1

Critical Pitfalls to Avoid

• Do not delay definitive surgical treatment in full-thickness disease hoping for medical management success
• Do not perform additional dental extractions without prophylactic pentoxifylline/tocopherol and antibiotics 1
• Address diabetes control aggressively as it doubles ORN risk and worsens outcomes 4
• Smoking cessation is mandatory given the 4-fold increased risk 3, 2

Bottom Line

Use the ClinRad staging system (I-III) with partial vs. full thickness descriptors as outlined in the 2024 ISOO-MASCC-ASCO guideline 1. This patient's multiple risk factors (>50 Gy, post-RT extractions, diabetes, smoking) place them at extremely high risk for severe, full-thickness ORN requiring segmental resection with free flap reconstruction. Traditional Notani, Marx, and RTOG systems are outdated and do not adequately guide contemporary treatment decisions.